Table 1.
Patient demographics: overall cohort, 360° and mixed coiling groups result.
| Overall N: 148 patients (157 aneurysms)* | 360° coiling N: 92 patients (100 aneurysms) | Mixed coiling N: 56 patients (57 aneurysms) | P | |
|---|---|---|---|---|
| Age, median (IQR) | 58.3 (48.1–67.4) | 57.9 (48–66.9) | 59.1 (48.4–70.4) | 0.5 |
| Gender, female | 73.0% (108) | 75% (69) | 69.6% (39) | 0.48 |
| Race | 0.21 | |||
| White/Caucasian | 71.6% (106) | 76.1% (70) | 64.3% (36) | |
| Black/African American | 10.8% (16) | 7.6% (7) | 16.1% (9) | |
| Hispanic/Latino | 13.5% (20) | 14.1% (13) | 12.5% (7) | |
| Other | 4.1% (6) | 2.2% (2) | 7.2% (4) | |
| Medical history | ||||
| Headache/migraine | 44.6% (66) | 48.9% (45) | 37.5% (21) | 0.19 |
| Previous stroke | ||||
| Hemorrhagic | 9.5% (14) | 7.6% (7) | 12.5% (7) | 0.53 |
| Ischemic | 9.5% (14) | 6.5% (6) | 14.3% (8) | 0.16 |
| Transient ischemic attack | 7.4% (11) | 6.5% (6) | 8.9% (5) | 0.86 |
| Family history intracranial aneurysm | 17.6% (26) | 20.6% (19) | 12.5% (7) | 0.39 |
| Diabetes | 16.9% (25) | 17.4% (16) | 16.1% (9) | 0.72 |
| Hypertension | 59.5% (88) | 62.0% (57) | 55.4% (31) | 0.50 |
| Smoking | 48.0% (71) | 45.7% (42) | 51.8% (29) | 0.45 |
| Arteriovenous malformation | 1.4% (2) | 2.2% (2) | 0% (0) | 0.48 |
| Polycystic kidney disease | 0.7% (1) | 1.1% (1) | 0% (0) | 0.29 |
| Hyperlipidemia | 37.8% (56) | 35.9% (33) | 41.1% (23) | 0.82 |
| Seizure | 6.8% (10) | 6.5% (6) | 7.1% (4) | 0.98 |
| Previously treated aneurysm | 7.0% (10) | 7% (6) | 8% (4) | 0.74 |
| Premorbid mRS∧ | 0.17 | |||
| 0 | 87.8% (130) | 91.3% (84) | 82.1% (46) | |
| 1 | 8.1% (12) | 7.6% (7) | 8.9% (5) | |
| 2 | 1.4% (2) | 0% (0) | 3.6% (2) | |
| 3 | 2.0% (3) | 1.1% (1) | 2.6% (2) |
*
One patient excluded for coils other than TARGET were used; and a second patient excluded due to baseline H&H of 4.∧mRS, modified Rankin's Scale.